Kepp, O., Deng, X., Xue, E., Sveinbjornsson, B., Rekdal, O., Galluzzi, L., Kroemer, G.

Oncolytic peptides (OLPs) constitute an emerging class of immunotherapeutics that combine direct cancer cell lysis with immune activation. Indeed, OLPs induce rapid immunogenic cell death by disrupting intracellular membranes, which culminates with th…